Anebulo Pharmaceuticals Statistics
Total Valuation
ANEB has a market cap or net worth of $19.62 million. The enterprise value is $10.58 million.
Important Dates
The last earnings date was Thursday, February 12, 2026, after market close.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ANEB has 40.78 million shares outstanding. The number of shares has increased by 55.97% in one year.
| Current Share Class | 40.78M |
| Shares Outstanding | 40.78M |
| Shares Change (YoY) | +55.97% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 40.84% |
| Owned by Institutions (%) | 3.22% |
| Float | 3.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.48 |
| P/TBV Ratio | 2.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.24
| Current Ratio | 6.24 |
| Quick Ratio | 6.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -30.60 |
Financial Efficiency
Return on equity (ROE) is -69.69% and return on invested capital (ROIC) is -49.69%.
| Return on Equity (ROE) | -69.69% |
| Return on Assets (ROA) | -45.04% |
| Return on Invested Capital (ROIC) | -49.69% |
| Return on Capital Employed (ROCE) | -114.70% |
| Weighted Average Cost of Capital (WACC) | -0.22% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.66M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.83% in the last 52 weeks. The beta is -0.81, so ANEB's price volatility has been lower than the market average.
| Beta (5Y) | -0.81 |
| 52-Week Price Change | -63.83% |
| 50-Day Moving Average | 1.28 |
| 200-Day Moving Average | 1.87 |
| Relative Strength Index (RSI) | 21.42 |
| Average Volume (20 Days) | 99,996 |
Short Selling Information
The latest short interest is 50,692, so 0.12% of the outstanding shares have been sold short.
| Short Interest | 50,692 |
| Short Previous Month | 58,049 |
| Short % of Shares Out | 0.12% |
| Short % of Float | 1.63% |
| Short Ratio (days to cover) | 0.81 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.10M |
| Pretax Income | -7.98M |
| Net Income | -7.98M |
| EBITDA | n/a |
| EBIT | -9.10M |
| Earnings Per Share (EPS) | -$0.19 |
Full Income StatementBalance Sheet
The company has $9.04 million in cash and n/a in debt, with a net cash position of $9.04 million or $0.22 per share.
| Cash & Cash Equivalents | 9.04M |
| Total Debt | n/a |
| Net Cash | 9.04M |
| Net Cash Per Share | $0.22 |
| Equity (Book Value) | 7.94M |
| Book Value Per Share | 0.19 |
| Working Capital | 7.79M |
Full Balance SheetCash Flow
| Operating Cash Flow | -5.84M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
